Intact Investment Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-8,800
Closed -$484K 298
2016
Q1
$484K Sell
8,800
-3,500
-28% -$191K 0.02% 195
2015
Q4
$760K Buy
12,300
+4,900
+66% +$309K 0.03% 156
2015
Q3
$467K Hold
7,400
0.02% 186
2015
Q2
$541K Sell
7,400
-1,700
-19% -$123K 0.02% 186
2015
Q1
$595K Buy
9,100
+1,700
+23% +$113K 0.02% 192
2014
Q4
$481K Hold
7,400
0.02% 220
2014
Q3
$445K Hold
7,400
0.02% 216
2014
Q2
$512K Hold
7,400
0.02% 178
2014
Q1
$484K Hold
7,400
0.02% 179
2013
Q4
$458K Hold
7,400
0.02% 162
2013
Q3
$397K Buy
+7,400
New +$381K 0.02% 174

Other funds holding STJ

Intact Investment Management's STJ Position: Q2 2016 in Review

Intact Investment Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 8,800 shares — an estimated $484K sold.

Intact Investment Management first reported a position in STJ in Q3 2013 and held it in 11 quarters. The position peaked at $760K in Q4 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Intact Investment Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • Intact Investment Management sold 8,800 St Jude Medical shares in Q2 2016, an estimated $484K.
  • Intact Investment Management first reported a position in St Jude Medical in Q3 2013 and held it in 11 quarters.
  • Intact Investment Management's St Jude Medical position peaked at $760K in Q4 2015.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Intact Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.